Sexual counseling in elderly couples

Journal of Sexual Medicine

Volumn 5, Issue 9, 2008, Pages 2027-2043

  Bitzer, Johannes ^a   Platano, Giacomo ^b   Tschudin, Sibil ^a   Alder, Judith ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Aging; Diagnostic Workup; Elderly Couple; Female and Male Sexual Dysfunctions; Multidisciplinary Therapies; Sexual Health

Indexed keywords

AMFEBUTAMONE; APOMORPHINE; ESTRADIOL; ESTRIOL; ESTROGEN; FLIBANSERIN; GESTAGEN; NITRIC OXIDE DONOR; PHOSPHODIESTERASE V INHIBITOR; PRASTERONE SULFATE; SEROTONIN UPTAKE INHIBITOR; SILDENAFIL; TADALAFIL; TESTOSTERONE; TIBOLONE; VARDENAFIL;

AGED; AGING; ATTITUDE TO SEXUALITY; BEHAVIOR THERAPY; BREAST CANCER; CARDIOVASCULAR DISEASE; CASE STUDY; COGNITIVE THERAPY; CULTURAL FACTOR; DECISION MAKING; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIZZINESS; DRUG CONTRAINDICATION; DRUG POTENTIATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPAREUNIA; ELDERLY CARE; ERECTILE DYSFUNCTION; FEMALE; FEMALE SEXUAL DYSFUNCTION; FLUSHING; GYNECOLOGY; HEADACHE; HEALTH CARE DELIVERY; HEALTH PRACTITIONER; HUMAN; HYPOTENSION; INDIVIDUALIZATION; INTERNAL MEDICINE; INTERNATIONAL CLASSIFICATION OF DISEASES; KNOWLEDGE BASE; LIBIDO DISORDER; LIFESTYLE; LONGEVITY; MALE; MASTURBATION; MEDICAL LITERATURE; MEDICAL SPECIALIST; MENOPAUSE; MENTAL HEALTH SERVICE; MORBIDITY; ORGASM; ORTHOSTATIC HYPOTENSION; PATIENT ATTITUDE; PREMATURE EJACULATION; PREVALENCE; PRIAPISM; PRIORITY JOURNAL; PROFESSIONAL COMPETENCE; PROSTATE DISEASE; PSYCHODYNAMICS; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGICAL ASPECT; PSYCHOTHERAPY; REVIEW; SEX ROLE; SEX THERAPY; SEXOLOGY; SEXUAL AROUSAL; SEXUAL AROUSAL DISORDER; SEXUAL BEHAVIOR; SEXUAL COUNSELING; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; SEXUAL HEALTH; SEXUAL INTERCOURSE; SEXUAL SATISFACTION; SIDE EFFECT; SOCIAL ASPECT; SOCIAL INTERACTION; SOCIAL PSYCHOLOGY; SWITZERLAND; SYNCOPE; TABOO; TREATMENT PLANNING; UNIVERSITY HOSPITAL; UROLOGY;

EID: 51349150422     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2008.00926.x     Document Type: Review

References (102)

1. Miller KE, Zylstra RG, Standridge JB. The geriatric patient: A systematic approach to maintaining health. Am Fam Physician 2000;61:1089-104.
2. Johnson B. Older adults' suggestions for health care providers regarding discussions of sex. Geriatr Nurs 1997;18:65-6.
3. Tan HM, Low WY, Ng CJ, Chen KK, Sugita M, Ishii N, Marumo K, Lee SW, Fisher W, Sand M. Prevalence and correlates of erectile dysfunction (ED) and treatment seeking for ED in Asian men: The Asian Men's Attitudes to Life Events and Sexuality (MALES) study. J Sex Med 2007;4:1582-92; [Epub].
4. Montague DK, Jarow JP, Broderick GA, Dmochowski RR, Heaton JP, Lue TF, Milbank AJ, Nehra A, Sharlip ID. Chapter 1: The management of erectile dysfunction: An AUA update. J Urol 2005;174:230-9.
5. Basson R. Female sexual response: The role of drugs in the management of sexual dysfunction. Obstet Gynecol 2001;98:350-3.
6. Cort E, Monroe B, Oliviere D. Couples in palliative care. Sex Marital Ther 2004;19:337-54.
7. Hayes RD, Dennerstein L. Aging issues. In: Goldstein I, Meston CM, Davis SR, Traish AM, eds. Women's sexual function and dysfunction. Abingdon: Francis and Taylor; 2006: 245-50.
8. Cain V, Johannes C, Avis N, Mohr B, Schocken M, Skurnick J, Ory M. Sexual functioning and practices in a multi-ethnic study of midlife women: Baseline results from SWAN. J Sex Res 2003;40:266-76.
9. Bergstrom-Walan M, Neilsen H. Sexual expression among 60 to 80 year old men and women: A sample from Stockholm, Sweden. J Sex Res 1990;27:289-95.
10. Feldman HA, Goldstein I, Hatzichristou DJ, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study. J Urol 1994;151:54-61.
11. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: Prevalence and predictors. JAMA 1999;281:537-44.
12. Araujo AB, Mohr BA, McKinlay JB. Changes in sexual function in middle-aged and older men: Longitudinal data from the Massachusetts Male Aging Study. J Am Geriatr Soc 2004;52:1502-9.
13. Bacon CG, Mittleman MA, Kawachi I, Giovannucci E. Sexual function in men older than 50 years of age: Results from the health professionals follow-up study. Ann Intern Med 2003;139:161-8.
14. Tressel Lindau S, Schumm LP, Laumann EO, Lewinson W, Muircheartaigh CA, Waite LJ. A study of sexuality and health among older adults in the United States. N Engl J Med 2007;357:762-74.
15. James WH. Decline in coital rates with spouses' ages and duration of marriage. J Biosoc Sci 1983;15:83-7.
16. Fugl Meyer AL, Fugl-Meyer K. Sexual disabilities, problems and satisfaction in 18-74 year old Swedes. Scand J Sexol 1999;2:79-105.
17. Smith LJ, Mulhall JP, Deveci S, Monaghan N, Reid MC. Sex after seventy: A pilot study of sexual function in older persons. J Sex Med 2007;4:1247-53.
18. Blümel JE, Castelo-Branco C, Cancelo MJ, Romero H, Aprikian D, Sarra S. Impairement of sexual activity in middle-aged women in Chile. Menopause 2004;11:78-81.
19. Sullivan ME, Keoghane SR, Miller MA. Vascular risk factors and erectile dysfunction. BJU Int 2001;87:838-45.
20. Nappi R, Salonia A, Traish AM, van Lunsen RH, Vardi Y, Kodiglu A, Goldstein I. Clinical biologic pathophysiologies of women's sexual dysfunction. J Sex Med 2005;2:4-25.
21. Chiurlia E, D'Amico R, Ratti C, Granata AR, Romagnoli R, Modena MG. Subclinical coronary artery atherosclerosis in patients with erectile dysfunction. J Am Coll Cardiol 2005;46:1503-6.
22. Esposito K, Giugliano F, Di Palo C, Giugliano G, Marfella R, D'Andrea F, D'Armiento M, Giugliano D. Effect of lifestyle changes on erectile dysfunction in obese men: A randomized controlled trial. JAMA 2004;291:2978-84.
23. Saenz de Tejada I, Goldstein I, Azadzoi K, Krane RJ, Cohen RA. Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N Engl J Med 1989;320:1025-30.
24. Bitzer J, Platano G, Tschudin S, Alder J. Sexual counseling for women in the context of physical diseases-A teaching model for physicians. J Sex Med 2007;4:29-37.
25. Bachmann GA, Leiblum SR. The impact of hormones on menopausal sexuality: A literature review. Menopause 2004;11:120-30.
26. Myers LS, Dixen J, Morrissette D, Carmichael M, Davidson J. Effects of estrogen, androgen, and progestin on sexual psychophysiology and behavior in postmenopausal women. J Clin Endocrinol Metab 1990;70:1124-31.
27. Dennerstein L, Dudley EC, Hopper JL, Burger H. Sexuality, hormones and the menopausal transition. Maturitas 1997;26:83-93.
28. Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 2001;86:724-31.
29. Salonia A, Briganti A, Montorsi P. Sexual dysfunction in women with coronary artery disease. Int J Impot Res 2002;14(4 suppl):80-6.
30. Salonia A. Medical conditions associated with female sexual dysfunction. In: Goldstein I, Meston CM, Davis SR, Traish AM, eds. Women's sexual function and dysfunction: Study, diagnosis and treatment. London: Taylor & Francis; 2006:263-75.
31. Panus RS, Mihailescu GD, Gomisiewicz MT, et al. Sex and arthritis. Bull Rheum Dis 2000;49:1-4.
32. Gutweniger S, Kopp M, Mur E, Gunter V. Body image of women with rheumatoid arthritis. Clin Exp Rheumatol 1999;17:413-7.
33. Cundiff GW, Fenner D. Evaluation and treatment of women with rectocele: Focus on associated defecatory and sexual dysfunction. Obstet Gynecol 2004;104:1403-21.
34. Wein AJ, Van Arsdalen KA. Drug-induced male sexual dysfunction. Urol Clin North Am 1988;15:23-31.
35. Slag MF, Morley JE, Elson MK, Trence DL, Nelson CJ, Nelson AE, Kinlaw WB, Beyer HS, Nuttall FQ, Shafer RB. Impotence in medical clinic outpatients. JAMA 1983;249:1736-40.
36. Grimm RH Jr, Grandits GA, Prineas RJ, McDonald RH, Lewis CE, Flack JM, Yunis C, Svendsen K, Liebson PR, Elmer PJ. Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS). Hypertension 1997;29:8-14.
37. Ko DT, Hebert PR, Coffey CS, et al. Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA 2002;288:351-7.
38. Reynolds CF, Frank E III, Thase ME, Houck PR, Jennings JR, Howell JR, Lilienfeld SO, Kupfer DJ. Assessment of sexual function in depressed, impotent, and healthy men: Factor analysis of a brief sexual function questionnaire for men. Psychiatry Res 1988;24:231-50.
39. Clayton AH, Pradko JF, Croft HA, Montano CB, Leadbetter RA, Bolden-Watson C, Bass KI, Donahue RM, Jamerson BD, Metz A. Prevalence of sexual dysfunction among newer antidepressants. J Clin Psychiatry 2002;63:357-66.
40. Althof SE, Leiblum SR, Chevret-Measson M, Hartmann U, Levine SB, McCabe M, Plaut M, Rodrigues O, Wylie K. Psychological and interpersonal dimensions of sexual function and dysfunction. J Sex Med 2005;2:793-800.
41. World Health Organization. International classification of disease. Geneva: WHO; 2006.
42. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th edition. Washington, DC: American Psychiatric Association; 2004.
43. Hawton K, Gath D, Day A. Sexual function in a community sample of middle-aged women with partners: Effect of age, marital, socioeconomic, psychiatric, gynecological and menopausal factors. Arch Sex Behav 1994;23:375-95.
44. Braunstein GD. Androgen insufficiency in women: Summary of critical issues. Fertil Steril 2002;77(4 suppl):S94-9.
45. Rellini A. Sexual abuse. In: Goldstein I, Meston CM, Davis SR, Traish AM, eds. Women's sexual function and dysfunction: Study, diagnosis and treatment. London: Taylor & Francis; 2006: 98-102.
46. Althof SE, Leiblum SR, Chevret-Measson M, Hartmann U, Levine SB, McCabe M, Plaut M, Rodrigues O, Wylie K. Psychological and interpersonal dimensions of sexual function and dysfunction. J Sex Med 2005;2:793-800.
47. Wiegel M, Scepkowski LA, Barlow DH. Cognitive and affective processes in female sexual dysfunctions. In: Goldstein I, Meston CM, Davis SR, Traish AM, eds. Women's sexual function and dysfunction: Study, diagnosis and treatment. London: Taylor & Francis; 2006:98-102.
48. Fung MM, Bettencourt R, Barrett-Connor E. Heart disease risk factors predict erectile dysfunction 25 years later: The Rancho Bernardo Study. J Am Coll Cardiol 2004;43:1405-11.
49. Sullivan ME, Keoghane SR, Miller MA. Vascular risk factors and erectile dysfunction. BJU Int 2001;87:838-45.
50. Grover SA, Lowensteyn I, Kaouache M, Marchand S, Coupal L, DeCarolis E, Zoccoli J, Defoy I. The prevalence of erectile dysfunction in the primary care setting: Importance of risk factors for diabetes and vascular disease. Arch Intern Med 2006;166:213-9.
51. Cocores JA, Miller NS, Pottash AC, Gold MS. Sexual dysfunction in abusers of cocaine and alcohol. Am J Drug Alcohol Abuse 1988;14:169-73.
52. Zincke H, Bergstralh EJ, Blute ML, Myers RP, Barrett DM, Lieber MM, Martin SK, Oesterling JE. Radical prostatectomy for clinically localized prostate cancer: Long-term results of 1,143 patients from a single institution. J Clin Oncol 1994;12:2254-63.
53. Mettlin CJ, Murphy GP, Sylvester J, McKee RF, Morrow M, Winchester DP. Results of hospital cancer registry surveys by the American College of Surgeons: Outcomes of prostate cancer treatment by radical prostatectomy. Cancer 1997;80:1875-81.
54. Zilbergeld B. The new male sexuality. New York; Toronto: Bantam Books; 1992.
55. Latini DM, Penson DF, Wallace KL, Lubeck DP, Lue TF. Clinical and psychosocial characteristics of men with erectile dysfunction: Baseline data from ExCEED. J Sex Med 2006;3:1059-67.
56. Clement U. Systemische Sexualtherapie. Stuttgart: Klett Cotta; 2004.
57. Leiblum S, Rosen R, eds. Principles and practice of sex therapy. New York: Guilford Press; 2000.
58. Vansteenwegen A. How can men and women in a couple bridge the difference between them. Sex Marital Ther 1998;13:439-48.
59. Gottman J, Silver N. The seven principles for making marriage work. New York: Crown Publishers; 1999.
60. Modelska K, Cummings S. Female sexual dysfunction in postmenopausal women: Systematic review of placebo-controlled trials. Am J Obstet Gynecol 2003;188:286-93.
61. Somboonporn W, Davis S, Seif MW, Bell R. Testosterone for peri- and postmenopausal women. Cochrane Database Syst Rev 2005; CD004509.
62. Simon J, Braunstein G, Nachtigall L, Utian W, Katz M, Miller S, Waldbaum A, Bouchard C, Derzko C, Buch A, Rodenberg C, Lucas J, Davis S. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. J Clin Endocrinol Metab 2005;90:5226-33.
63. Buster JE, Kingsberg SA, Aguirre O, Brown C, Breaux JG, Buch A, Rodenberg CA, Wekselman K, Casson P. Testosterone patch for low sexual desire in surgically menopausal women: A randomized trial. Obstet Gynecol 2005;105(5 Pt 1):944-52.
64. Shifren JL, Davis SR, Moreau M, Waldbaum A, Bouchard C, DeRogatis L, Derzko C, Beamson P, Kakos N, O'Neill S, Levine S, Wekselman K, Buch A, Rodenberg C, Kroll R. Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women. Results of the INTIMATE NM1 study. Menopause 2006;13:770-9.
65. NAMS Advisory Panel. Estrogen and progestogen use in peri- and postmenopausal women: March 2007 positions statement of the North American Menopause Society. Menopause 2007;14:168-72.
66. Somboonporn W, Davis SR. Testosterone effects on the breast: Implications for testosterone therapy for women. Endocr Rev 2004;25:374-88.
67. Laan E, van Lunsen RH, Everaerd W. The effects of tibolone on vaginal blood flow, sexual desire and arousability in postmenopausal women. Climacteric 2001;4:28-41.
68. Conner P. Breast response to menopausal hormone therapy-Aspects on proliferation, apoptosis and mammographic density. Ann Med 2007;39:28-41.
69. Beral V. Million Women Study Collaborators: Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003;362:419-27.
70. Goldstein I, Alexander JL. Practical aspects in the management of vaginal atrophy and sexual dysfunction in perimenopausaland postmenopausal women. J Sex Med 2005;2(3 suppl):154-65.
71. Basson R, Mcinnes R, Smith MD, Hodgson G, Koppiker N. Efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal disorder. J Womens Health Gend Based Med 2002;11:367-77.
72. Berman JR, Berman LA, Toler SM, Gill J, Haughie S. Safety and efficacy of sildenafil citrate for the treatment of female sexual arousal disorder: A double-blind, placebo controlled study. J Urol 2003;170:2333-8.
73. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med 1998;338:1397-404.
74. Hellstrom WJ, Gittelman M, Karlin G, Segerson T, Thibonnier M, Taylor T, Padma-Nathan H. Sustained efficacy and tolerability of vardenafil, a highly potent selective phosphodiesterase type 5 inhibitor, in men with erectile dysfunction: Results of a randomized, double-blind, 26-week placebo-controlled pivotal trial. Urology 2003;61:8-14.
75. Porst H, Padma-Nathan H, Giuliano F, Anglin G. Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: A randomized controlled trial. Urology 2003;62:121-5.
76. Rendell MS, Rajfer J, Wicker PA, Smith MD for the Sildenafil Diabetes Study Group. Sildenafil for treatment of erectile dysfunction in men with diabetes. A randomized controlled trial. JAMA 1999;281:421-6.
77. Schover LR, Fouladi RT, Warneke CL, Neese L, Klein EA, Zippe C, Kupelian PA. The use of treatments for erectile dysfunction among survivors of prostate carcinoma. Cancer 2002;95:2397-407.
78. Fink HA, MacDonald R, Rutks IR, Nelson DB, Wilt TJ. Sildenafil for male erectile dysfunction. A systematic review and meta-analysis. Arch Intern Med 2002;162:1342.
79. Reffelmann T, Kloner RA. Cardiovascular effects of phosphodiesterase 5 inhibitors. Curr Pharm Des 2006;12:3485-94.
80. Dunn ME, Althof SE, Perelman MA. Phosphodiesterase type 5 inhibitors' extended durations of response as a variable in the treatment of erectile dysfunction. Int J Impot Res 2007;19:119-23.
81. Taneja R. A rational combination pharmacotherapy in men with erectile dysfunction who initially failed to oral sildenafil citrate alone: A pilot study. J Sex Med 2007;4(4 Pt 2):1136-41; [Epub].
82. Guay AT, Spark RF, Bansal S, etal. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of male sexual dysfunction: A couple's problem-2003 update. Endocr Pract 2003;9:77-82.
83. Banner LL, Anderson RU. Integrated sildenafil and cognitive-behavior sex therapy for psychogenic erectile dysfunction: A pilot study. J Sex Med 2007; 4(4 Pt 2):1117-25.
84. Heiman JR, Talley DR, Bailen JL, Oskin TA, Rosenberg SJ, Pace CR, Creanga DL, Bavendam T. Sexual function and satisfaction in heterosexual couples when men are administered sildenafil citrate (Viagra) for erectile dysfunction: A multicentre, randomised, double-blind, placebo-controlled trial. BJOG 2007;114:437-47.
85. Goldstein I, Fisher WA, Sand M, Rosen RC, Mollen M, Brock G, Karlin G, Pommerville P, Bangerler K, Bandel TJ, DeRogatis L. Women's sexual functions improves when partners are administered vardenafil for erectile dysfunction: A prospective, randomized, double-blind, placebo-controlled trial. J Sex Med 2005;2:819-32.
86. Montague DK, Jarow J, Broderick GA, Dmochowski RR, Heaton JP, Lue TF, Nehra A, Sharlip ID. AUA guideline on the pharmacologic management of premature ejaculation. J Urol 2004;172:290-4.
87. Shabsigh R, Kaufman JM, Steidle C, Padma-Nathan H. Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. J Urol 2004;172:658-63.
88. Bain J, Brock G, Kuzmarov I, International Consulting Group. Canadian Society for the Study of the Aging Male: Response to health Canada's position paper on testosterone treatment. J Sex Med 2007;4:558-66.
89. Panjari M, Davis SR. DHEA therapy for women: Effect on sexual function and wellbeing. Hum Reprod Update 2007;13:239-48.
90. Caruso S, Agnello C, Intelisano G, Farina M, Di Mari L, Cianci A. Placebo-controlled study on efficacy and safety of daily apomorphine SL intake in premenopausal women affected by hypoactive sexual desire disorder and sexual arousal disorder. Urology 2004;63:955-9.
91. Clayton AH, Warnock JK, Kornstein SG, Pinkerton R, Sheldon-Keller A, McGarvey EL. A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction. J Clin Psychiatry 2004;65:62-7.
92. Barbach L. For yourself. Berlin: Ullstein; 1977.
93. LoPiccolo J, LoPiccolo L, eds. Handbook of sex therapy. New York: Plenum; 1978.
94. Masters WH, Johnson VE. Human sexual inadequacy. Boston, MA: Little Brown; 1970.
95. Levine SB, Risen CB, Althof SE, eds. Handbook of clinical sexology for mental health professionals. New York: Houve Brunner Routledge; 2003.
96. Althof SE, Banner L. Difficult cases: Psychologic treatment of desire, arousal and orgasm disorders. In: Goldstein I, Meston CM, Davis SR, Traish AM, eds. Women's sexual function and dysfunction: Study, diagnosis and treatment. London: Taylor & Francis; 2006:462-7.
97. Brotto LA. Psychologic-based desire and arousal disorder: Treatment strategies and outcome results. In: Goldstein I, Meston CM, Davis SR, Traish AM, eds. Women's sexual function and dysfunction: Study, diagnosis and treatment. London: Taylor & Francis; 2006: 441-8.
98. Fugl-Meyer AR, Fugl-Meyer KS. Prevalence data in Europe. In: Goldstein I, Meston CM, Davis SR, Traish AM, eds. Women's sexual function and dysfunction: Study, diagnosis and treatment. London: Taylor & Francis; 2006:34-41.
99. Parish SJ. Role of the primary care and internal medicine clinician. In: Goldstein I, Meston CM, Davis SR, Traish AM, eds. Women's sexual function and dysfunction: Study, diagnosis and treatment. London: Taylor & Francis; 2006:689-95.
100. Kang D, Ducharme SH. Integration of medical and psychologic diagnosis and treatement. In: Goldstein I, Meston CM, Davis SR, Traish AM, eds. Women's sexual function and dysfunction: Study, diagnosis and treatment. London: Taylor & Francis; 2006:721-8.
101. Brock G, Carrier S, Casey R, Tarride JE, Elliott S, DugréH, Rousseau C, D'Angelo P, Defoy I. Can an educational program optimize PDE5i therapy? A study of Canadian primary care practices. J Sex Med 2007;4:1404-13; [Epub].
102. Chitale S, Collins R, Hull S, Smith E, Irving S. Is the current practice providing an integrated approach to the management of LUTS and ED in primary care? An audit and literature review. J Sex Med 2007;4:1713-25; [Epub]. Review.